Author response for "Dapagliflozin modulates hepatic lipid metabolism through the proprotein convertase subtilisin/kexin type 9/low density lipoprotein receptor pathway"

Fengyuan Lu(Second Affiliated Hospital of Zhengzhou University), Xiaoyu Yang(Huazhong University of Science and Technology), Lijuan Kong(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Zhang(Ministry of Education of the People's Republic of China), En Li, Yifeng Gao(German Cancer Research Center)
Unknown
December 16, 2024
Cited by 0


Related Papers